Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of Stem Cell Transplantation in Multiple Myeloma
Srinivas Devarakonda, Yvonne A. Efebera, Nidhi Sharma
Cancers (2021) Vol. 13, Iss. 4, pp. 863-863
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Progress and prospect of ASCT combined with CAR-T therapy in the treatment of multiple myeloma
S. Yuan, Ying Chen, Huasheng Liu
Therapeutic Advances in Hematology (2024) Vol. 15
Open Access | Times Cited: 6
An overview of multiple myeloma: A monoclonal plasma cell malignancy’s diagnosis, management, and treatment modalities
Maisa Siddiq Abduh
Saudi Journal of Biological Sciences (2023) Vol. 31, Iss. 2, pp. 103920-103920
Open Access | Times Cited: 12
Delayed diagnosis of multiple myeloma in a young patient: a call for vigilance in diagnosis
Jigar Patel, Seta Degann, Mohammad Ahmad, et al.
BMJ Case Reports (2025) Vol. 18, Iss. 1, pp. e262158-e262158
Closed Access
Optimizing Autologous Stem Cell Transplantation in Multiple Myeloma: The Significance of Pre-Transplant Controlling Nutritional Status Score
Sıdıka Gülkan Özkan, Suna Avcı, Ali Kimiaei, et al.
Life (2025) Vol. 15, Iss. 2, pp. 289-289
Open Access
Etoposide + cytarabine + pegfilgrastim versus cyclophosphamide + G-CSF for stem cell mobilization in patients with poorly mobilized multiple myeloma and lymphoma
Yixuan Cheng, Shuting Xu, Renzhi Pei, et al.
Transfusion and Apheresis Science (2025), pp. 104096-104096
Closed Access
Recent advancements in nanomedicine as a revolutionary approach to treating multiple myeloma
Fatemeh Sadat Shafiei, Saeid Abroun
Life Sciences (2024) Vol. 356, pp. 122989-122989
Closed Access | Times Cited: 3
Differential Diagnosis and Therapeutic Advances in Multiple Myeloma: A Review Article
Munawwar Hussain, Sarvari V. Yellapragada, Samer Al Hadidi
Blood and Lymphatic Cancer Targets and Therapy (2023) Vol. Volume 13, pp. 33-57
Open Access | Times Cited: 7
Updates on Therapeutic Strategies in the Treatment of Relapsed/Refractory Multiple Myeloma
Deevyashali Parekh, Yun Kyoung Tiger, Kevin Tony Jamouss, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 2931-2931
Open Access | Times Cited: 2
GPC-100, a novel CXCR4 antagonist, improves in vivo hematopoietic cell mobilization when combined with propranolol
Devki Sukhtankar, Juan José Fung, Mi‐Na Kim, et al.
PLoS ONE (2023) Vol. 18, Iss. 10, pp. e0287863-e0287863
Open Access | Times Cited: 6
Changing paradigms in the treatment of multiple myeloma
J Bladé, Laura Rosiñol
Haematologica (2009) Vol. 94, Iss. 2, pp. 163-166
Open Access | Times Cited: 24
Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma
Fortunato Morabito, Giovanni Tripepi, Enrica Antonia Martino, et al.
Drug Design Development and Therapy (2021) Vol. Volume 15, pp. 2969-2978
Open Access | Times Cited: 14
Major advances in the treatment of multiple myeloma in American Society of Hematology annual meeting 2020
Jianhua Du, Junling Zhuang
Chronic Diseases and Translational Medicine (2021) Vol. 7, Iss. 4, pp. 220-226
Open Access | Times Cited: 14
Safety of Cryopreserved Stem Cell Infusion through a Peripherally Inserted Central Venous Catheter
Sławomir Milczarek, Piotr Kulig, Alina Zuchmańska, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1338-1338
Open Access | Times Cited: 5
Partnering With All Patients: Ensuring Shared Decision Making and Evidence-Based Management for Underrepresented Groups With Multiple Myeloma
Claudio Cerchione, Shakira J. Grant, Sikander Ailawadhi
American Society of Clinical Oncology Educational Book (2023), Iss. 43
Open Access | Times Cited: 5
Advances in adoptive cellular immunotherapy and therapeutic breakthroughs in multiple myeloma
Jingjing Pu, Ting Liu, Amit Sharma, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Higher efficacy of Etoposide + Cytarabine Plus Pegfilgrastim in poorly mobilizing Multiple Myeloma and lymphoma Patients
Peipei Ye, Renzhi Pei, Jiaying Lian, et al.
Cytotherapy (2023) Vol. 25, Iss. 8, pp. 885-890
Closed Access | Times Cited: 2
Quercetin inhibits the proliferation of multiple myeloma cells by upregulating PTPRR expression
Houcai Wang, Dandan Yu, Hui Zhang, et al.
Acta Biochimica et Biophysica Sinica (2021) Vol. 53, Iss. 11, pp. 1505-1515
Open Access | Times Cited: 5
Adjuvant therapy with zinc supplementation; anti-inflammatory and anti-oxidative role in multiple myeloma patients receiving autologous hematopoietic stem cell transplantation: a randomized controlled clinical trial
Kasra Jahankhani, Niloofar Taghipour, Maryam Nikoonezhad, et al.
BioMetals (2024)
Closed Access
Bortezomib, lenalidomide, and dexamethasone versus bortezomib, doxorubicin, and dexamethasone in newly diagnosed multiple myeloma
Dong Liang, Shenrui Bai, Demei Feng, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
Tumour Immunotherapy and Applications of Immunological Products: A Review of Literature
Angus Nnamdi Oli, Samson Adedeji Adejumo, Adekunle Babajide Rowaiye, et al.
Journal of Immunology Research (2024) Vol. 2024, Iss. 1
Open Access
Impact of gut colonization by antibiotic-resistant bacteria on the outcomes of autologous stem cell transplantation in multiple myeloma
Marcin Jasiński, Jarosław Biliński, Martyna Maciejewska, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Prehabilitation Exercise Training to Target Improved Muscle Strength in Pretransplant Patients Diagnosed With Multiple Myeloma: Protocol for a Pilot Randomized Controlled Trial
Amber J. Normann, Clifton C. Mo, Rebekah L. Wilson, et al.
JMIR Research Protocols (2024) Vol. 13, pp. e64905-e64905
Open Access
Prehabilitation Exercise Training to Target Improved Muscle Strength in Pretransplant Patients Diagnosed With Multiple Myeloma: Protocol for a Pilot Randomized Controlled Trial (Preprint)
Amber J. Normann, Clifton C. Mo, Rebekah L. Wilson, et al.
(2024)
Closed Access
Prospective Comparative Study of Etoposide plus G-CSF versus G-CSF Alone, Followed by Risk-Adapted Plerixafor for Peripheral Blood Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma: Catholic Research Network for Multiple Myeloma Study (CARE-MM 2001)
Sung‐Soo Park, Chang‐Ki Min, Young‐Woo Jeon, et al.
(2023)
Open Access | Times Cited: 1
The first relapse in multiple myeloma: how to pick the next best thing
Srinivas Devarakonda, Nidhi Sharma, Yvonne A. Efebera
Hematology (2022) Vol. 2022, Iss. 1, pp. 560-568
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top